Ashour appreciates the support of the political leadership to improve oncology services in university hospitals
Dr. Ayman Ashour, Minister of Higher Education and Scientific Research, witnessed the signing of a memorandum of understanding between Cairo University and the “Ovarian Cancer Cell Laboratory.” The agreement was signed by Dr. Mohamed Sami Abdel Sadiq, President of Cairo University, Dr. Ahmed Ahmed, representative of the University of Oxford, Mr. Kevin Kyle, CEO of Germfree, and Mr. Boro Droblik, at the University of Oxford, Germfree, and Caring Cross Health Foundation.
Executive Director of the Caring Cross Foundation, in the presence of Dr. Mustafa Refaat, Secretary of the Supreme Council of Universities, Dr. Mahmoud Al-Saeed, Vice President of the University for Scientific Research Affairs, and Dr. Ahmed Ragab, Vice President of the University for Education and Student Affairs, Dr. Mohamed Abdel Moati, Director of the National Cancer Institute, and Dr. Dalia Qadry, Director General of Hospitals at the Institute.
Dr. Ashour stressed the importance of this agreement in supporting the university hospital system, especially in the field of oncology treatment, pointing to the efforts made by the Ministry during The past period has aimed to improve the quality of services provided to oncology patients, through establishing partnerships with prestigious international institutions, and expanding the infrastructure of university hospitals, specifically specialized in treating oncology.
The Minister also appreciated the support provided by the political leadership. To develop university hospitals, pointing to the state’s interest in the field of oncology treatment by encouraging scientific research, raising the efficiency of medical staff, and developing hospital infrastructure, which contributes to strengthening Egypt’s position as a regional center for oncology treatment in the region, adding the importance of this trend in supporting the provision of distinguished medical services. In the hope of recovery for citizens afflicted with this serious disease, and for patients arriving for treatment from abroad, especially in light of the global increase in tumor rates.
The Minister praised the role of Cairo University with its human capabilities and hospitals. Distinguished, and being a pioneer in oncology treatment. He also referred to the 500500 Oncology Hospital project, which enjoys great support from the state, to become the largest cancer treatment hospital in the region. He thanked the President of Cairo University for its efforts in strengthening its international partnerships in this field, and the Supreme Council of Universities for its sponsorship. For this agreement, he expressed his aspiration to enhance the capabilities of university hospitals at Cairo University in the field of oncology treatment, valuing the distinguished position of the University of Oxford and the institutions participating in cooperation in the field of care. Health.
Dr. Mohamed Sami Abdel Sadiq welcomed the attendees, stressing that this agreement represents a major step towards enhancing Egypt’s position in the field of oncology treatment and developing advanced treatments, in order to achieve a qualitative leap in health and research services. He stressed Cairo University’s keenness to Supporting its leadership in the field of oncology treatment in the region, and opening horizons of cooperation with distinguished international institutions in this field, whether in treatment and scientific research, in a way that benefits the medical service provided to citizens.
The President of Cairo University explained that the memorandum of understanding aims to Enhancing cooperation between the signatory parties in accelerating clinical research and development, and designing and building manufacturing facilities and approving innovative treatments such as CAR-T cells and other advanced cell therapies.
The memorandum of understanding includes Cairo University equipping CAR-T cell manufacturing facilities, And establishing a facility for manufacturing vector viruses, in addition to training and employing the necessary scientific personnel, conducting clinical trials, and developing research in cooperation with the Caring Cross Foundation.
The role of the University of Oxford also includes providing oversight and supervisory support for activities. Cooperation, and enhancing research cooperation between Cairo University and the Caring Cross Foundation to develop new treatments for solid tumors.
The memorandum of understanding also includes the initiatives of the Caring Cross Foundation, which aim to transfer the technology of manufacturing CAR-T cells and vector viruses to Cairo University, and provide products. Ready-made cellular and viral diseases, in addition to training scientific teams at Cairo University online and in the field, and providing technical support and quality to ensure standardization, as well as cooperation with Oxford University to support clinical trials and develop treatments. New.
It should be noted that the Ovarian Cancer Cell (OCC) Laboratory at the University of Oxford is focused on developing new immunotherapy strategies for the treatment of solid tumors. He also has extensive experience in cancer genomics and modeling tumor pathogenesis and treatment resistance. The Kering Cross Foundation is an American non-profit organization specializing in the development and implementation of advanced cell therapies (ATMPs), with extensive experience in this field. The American company Germfree is one of the leading institutions in designing advanced, environmentally friendly manufacturing facilities for advanced cell therapies, offering flexible, modular designs to suit various needs.
